Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
BREXUCABTAGENE AUTOLEUCEL (TECARTUS) INFUSION - B-ALL (OTHER 200118) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/200118/by-state?code_type=OTHER
“BREXUCABTAGENE AUTOLEUCEL (TECARTUS) INFUSION - B-ALL (OTHER 200118) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/200118/by-state?code_type=OTHER. Accessed
June 30, 2026 .
“BREXUCABTAGENE AUTOLEUCEL (TECARTUS) INFUSION - B-ALL (OTHER 200118) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/200118/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
200118 — Brexucabtagene Autoleucel (tecartus) Infusion - B-all
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$212,000
National median
$80 – $900,663
IQR (p25 – p75)
4
hospitals filing
3
states
Walking in without insurance?
Cash / self-pay price
Cash median
$3,436
vs. negotiated
-98.4%
Hospitals reporting
4
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 200118 (OTHER), with interquartile range
State Median p25 p75
CT $877,800 $368,140 $1,208,130
TX $1,414 $545 $2,447
MI $66 $60 $87